Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Malignant Solid Neoplasm 2Teratoma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Peritoneal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Acute 1Hepatitis B 1Hematopoietic and Lymphatic System Neoplasm 1Endodermal Sinus Tumor 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Carcinoma, Embryonal 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cytarabine 2pegaspargase 1palbociclib 1carmustine, poliferprosan 20 drug combination 1Vincristine 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Prednisone 1Prednisolone 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Hydrocortisone 1Hematopoietic Stem Cell Mobilization 1Etoposide 1Drug Therapy 1Doxorubicin 1Carmustine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, T-Cell × Practice Guidelines as Topic × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡